NCT01206621

Brief Summary

For the patient with acute dyspnea in the ED, early differentiation between CHF and non-CHF causes is essential for proper management. The capacity to triage patients quickly and accurately has a beneficial impact upon outcome, disposition, stratification and length of stay in the ED and required length of hospital admission. The ability to assess pulmonary status rapidly by quantitative regional vibration technology offers significant potential advantage for earlier diagnosis. The VRI technique may provide a quick and accurate method of differentiating between dyspnea due to HF and dyspnea due to pulmonary causes; thereby improving management and outcomes.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
530

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Aug 2010

Shorter than P25 for all trials

Geographic Reach
2 countries

8 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 21, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 22, 2010

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
Last Updated

May 13, 2011

Status Verified

September 1, 2010

Enrollment Period

10 months

First QC Date

September 21, 2010

Last Update Submit

May 12, 2011

Conditions

Keywords

dyspneaCOPDCHFasthma

Outcome Measures

Primary Outcomes (1)

  • Assess the ability of the VRI to improve clinical outcomes via accurate, early classification of the cause of acute dyspnea as HF or other (i.e. COPD, PE etc).

    The primary efficacy analysis set (PEAS) consists of all patients who have Gold Standard (GS) diagnosis (CHF/non-CHF) \& VRI records. * Accuracy rate is defined as the accuracy between the GS and VRI. * Accuracy parameters between the GS and VRI will be calculated using accuracy rate, sensitivity, specificity, negative predictive value (NPV), positive predictive value (PPV) \& likelihood ratios (+,-).

    Baseline testing at ED presentation

Secondary Outcomes (3)

  • Assess the agreement to aid in classifying the cause of acute dyspnea as HF or other of the VRI in comparison to BNP/NTproBNP assays.

    Baseline testing at ED presentation

  • Assess the ability of the VRI to aid in classifying the cause of acute dyspnea as HF or COPD

    Baseline testing at ED presentation

  • Evaluate the ability of the VRI to monitor changes in clinical status following treatment in comparison with other standard testing methods (e.g. ECG, serial chest x-rays, etc.)

    Baseline testing and repeated testing after 2 hours

Study Arms (1)

ED patients presenting with dyspnea

Eligibility Criteria

Age41 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients presenting to the ED with acute dyspnea who are greater than 40 years of age and consisting of both male and females

You may qualify if:

  • Able and willing to provide Informed Consent;
  • \>40 years of age;
  • Estimated Body Mass Index \>19;
  • Patient presented to the emergency department with a chief complaint of acute dyspnea.

You may not qualify if:

  • Patients with obvious trauma or acute anxiety as a cause of dyspnea;
  • Patient has already received directed therapy in the ED and symptoms are remarkably improved;
  • Physician concern regarding possible harm to patient caused by positioning or ambulating the patient for VRI testing;
  • Intubated or mechanically ventilated;
  • Acute hemodynamic or ventilator instability requiring immediate resuscitation;
  • Body habitus or skin condition that might prevent the placement of the sound sensors on the back (e.g. severe scoliosis, kyphosis, chest wall deformation, skin lesion on the back or compression fracture);
  • Hirsutism.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

Christiana Care Health System

Newark, Delaware, 19718, United States

RECRUITING

University of Nevada School of Medicine

Las Vegas, Nevada, 89106, United States

NOT YET RECRUITING

Mount Sinai School of Medicine

New York, New York, 10029, United States

RECRUITING

Lincoln Medical and Mental Health Center

The Bronx, New York, 10451, United States

RECRUITING

Metrohealth Medical Center

Cleveland, Ohio, 44122, United States

RECRUITING

Pennsylvania Hospital

Philadelphia, Pennsylvania, 19107, United States

RECRUITING

Baylor College of Medicine

Houston, Texas, 77030, United States

NOT YET RECRUITING

Beilinson Hospital, Rabin Medical Center

Petah Tikva, 49100, Israel

NOT YET RECRUITING

Related Publications (3)

  • Wang Z, Bartter T, Baumann BM, Abouzgheib W, Chansky ME, Jean S. Asynchrony between left and right lungs in acute asthma. J Asthma. 2008 Sep;45(7):575-8. doi: 10.1080/02770900802017744.

    PMID: 18773329BACKGROUND
  • Guntupalli KK, Reddy RM, Loutfi RH, Alapat PM, Bandi VD, Hanania NA. Evaluation of obstructive lung disease with vibration response imaging. J Asthma. 2008 Dec;45(10):923-30. doi: 10.1080/02770900802395496.

    PMID: 19085584BACKGROUND
  • Dellinger RP, Parrillo JE, Kushnir A, Rossi M, Kushnir I. Dynamic visualization of lung sounds with a vibration response device: a case series. Respiration. 2008;75(1):60-72. doi: 10.1159/000103558. Epub 2007 Jun 4.

    PMID: 17551264BACKGROUND

Biospecimen

Retention: NONE RETAINED

Blood drawn for BNP testing

MeSH Terms

Conditions

DyspneaPulmonary Disease, Chronic ObstructiveAsthma

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsLung Diseases, ObstructiveLung DiseasesChronic DiseaseDisease AttributesPathologic ProcessesBronchial DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • Charles V. Pollack, MD

    Pennsylvania Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Charles V. Pollack, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY

Study Record Dates

First Submitted

September 21, 2010

First Posted

September 22, 2010

Study Start

August 1, 2010

Primary Completion

June 1, 2011

Study Completion

June 1, 2011

Last Updated

May 13, 2011

Record last verified: 2010-09

Locations